EP1781719A1 - Utilisation de copolymeres amphiphiles comme agents de solubilisation - Google Patents

Utilisation de copolymeres amphiphiles comme agents de solubilisation

Info

Publication number
EP1781719A1
EP1781719A1 EP05783769A EP05783769A EP1781719A1 EP 1781719 A1 EP1781719 A1 EP 1781719A1 EP 05783769 A EP05783769 A EP 05783769A EP 05783769 A EP05783769 A EP 05783769A EP 1781719 A1 EP1781719 A1 EP 1781719A1
Authority
EP
European Patent Office
Prior art keywords
monomer
mol
copolymers
sub
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05783769A
Other languages
German (de)
English (en)
Inventor
Marianna Pierobon
Nathalie Bouillo
Ronald Frans Maria Lange
Kathrin Meyer
Karl Kolter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of EP1781719A1 publication Critical patent/EP1781719A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C08F226/06—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a heterocyclic ring containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Definitions

  • amphiphilic copolymers as solubilizers
  • the present invention relates to the use of copolymers obtainable by polymerization of monoethylenically unsaturated carboxylic acid esters with N-vinylamides, N-vinyllactams, N-vinylamines or N-vinylimines, as solubilizers.
  • Solubilization is understood to mean a solubility improvement by surface-active compounds which are capable of converting poorly water-soluble or water-insoluble substances into clear, at most opalescent aqueous solutions, without the chemical structure of these substances undergoing any change.
  • solubilizates prepared are characterized in that the poorly water-soluble or water-insoluble substance is present dissolved in the molecular associates of the surface-active compounds which form in aqueous solution.
  • the resulting solutions are stable single-phase systems that appear optically clear to opalescent and can be prepared without energy input.
  • solubilizers can improve the appearance of cosmetic formulations as well as food preparations by making the formulations transparent.
  • the bioavailability and thus the effect of drugs can be increased by the use of solubilizers.
  • solubilizers used for pharmaceutical drugs and cosmetic active ingredients are mainly the following products:
  • ethoxylated (hydrogenated) castor oil for example, Cremophor ® brands from BASF.
  • ethoxylated sorbitan eg Tween ® brands, ICI.
  • ethoxylated hydroxystearic eg Solutol ® brands, Fa. BASF.
  • solubilizers described above used so far, show a number of application disadvantages.
  • the known solubilizers spielmud for some sparingly soluble drugs such as clotrimazole, or active or Dyes only a small solubilizing effect.
  • the solubilizers mentioned are not suitable for use in solid solutions.
  • EP-A 0 876 819 relates to the use of copolymers of N-vinylpyrrolidone and alkylacrylic acids as solubilizers.
  • EP-A 0 953 347 relates to the use of polyalkylene oxide-containing graft polymers as solubilizers.
  • EP-A 0 948 957 describes the use of copolymers of monoethylenically unsaturated carboxylic acids as solubilizers.
  • Microporous ultrafiltration membranes are known from US Pat. No. 5,942,120, which consist of a hydrophobic polymer and a water-insoluble addition copolymer, the copolymer being made of special alkylphenoxy-polyalkylene glycol acrylates on the one hand and a compound selected from the group of vinylsulfonic acids, acrylamides , N-substituted acrylamides, acrylonitriles, lower alkyl (meth) acrylates, N-vinyl-pyrrolidone or mixtures thereof.
  • JP-A 09 241 335 relates to a crosslinked polymer which is obtained by polymerization of at least one N-vinyl monomer selected from the group consisting of N-vinyl lactams, N-vinyll amides, N-vinyl oxazolidones, N-vinyl Vinylcarbamaten and N-vinylimides on the one hand and special oxyalkylen faced (meth) acrylic esters on the other hand and their use for the production of flame retardant materials.
  • R1 and R2 are each independently H or CH 3,
  • alkoxy substituents may inertial C 12 aralkyl, the one or more identical or different -C 9 -alkyl and / or C r C, and - R 3 is C 6 -C 10 aryl or C 7
  • n is an integer from 0 to 100
  • copolymers to be used according to the invention are obtainable by polymerization of at least one copolymerizable monomer of the formula (I) (monomer A)
  • the radicals R 1 and R 2 may each independently of one another have the meanings H and / or methyl. They are thus derivatives of acrylic acid and / or methacrylic acid.
  • the radical R 3 is a C 6 -C 10 -aryl radical, for example phenyl or naphthyl, or a C 7 -C 12 -aralkyl radical, for example benzyl, phenylethyl or phenylpropyl.
  • the radicals mentioned for R 3 may carry one or more, usually 1 to 3, identical or different C 1 -C 9 -alkyl and / or C 1 -C 5 -alkoxy substituents which are straight-chain or branched, or open-chain, cyclic or alicyclic.
  • suitable C 1 -C 6 -alkyl substituents are: methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, 1, 1-dimethylethyl, 1-pentyl, 2-pentyl, 1-hexyl, cyclohexyl, 1-heptyl, 1-octyl, 1-nonyl.
  • radicals R3 are, for example: phenyl, para-tolyl, benzyl, para-hydroxybenzyl, para-hydroxyphenyl, para-methoxyphenyl, para-methoxybenzyl or cyclohexyl.
  • n in formula (I) denotes an integer from 0 to 100, preferably from 1 to 100, particularly preferably from 1 to 25 and in particular from 1 to 10. If n is a number greater than 1, the radicals R 2 can be the each repetition units have the same meaning or independently, optionally randomly distributed, each represents H or CH 3 . Are in this case preferably from about 50% to about 100% of the radicals R2 are H and about 0 to about 50% of the radicals R 2 is CH 3. In a preferred embodiment of the method according to the invention take in the case that n is a number greater than 1, all radicals have the same meaning. Particularly preferred R2 then H.
  • copolymerizable monomers of the formula (I) are obtainable by methods known per se to those skilled in the art for the synthesis of esters, for example in Vollhardt, Peter; Organic Chemistry, pages 768-774, 1988, VCH, New York, or also described in EP-A 646567.
  • Copolymers which can be used according to the invention are obtained by polymerization of monomer mixtures which as a rule contain from about 0.1 to 99.9 mol%, based on the total amount of the monomers used, of the at least one monomer A. Monomer mixtures about 1 to about 50 mol%, more preferably about 1 to about 30 mol% of the at least one monomer A.
  • the monomers A can in pure form or in the form of mixtures of two or more different compounds as they Formula (I) are defined, are used.
  • At least one further copolymerizable monomer (monomer B) is used, which is selected from the substance groups of the N-vinylamides, the N-vinyllactams, the N-vinylimines and / or the N-vinyl amines.
  • the selected monomers generally have 2 to 15 carbon atoms, preferably 2 to 10 carbon atoms.
  • N-vinyl amides or N-vinyl lactams are exemplified those which are characterized by the following formula (II):
  • R4, R5 independently of one another are H or C r C 6 -alkyl or may together form a 4- to 8-membered cycle which may be saturated or monounsaturated or polyunsaturated and may optionally carry further substituents.
  • Suitable open-chain compounds of this type are, for example, N-vinylformamide, N-vinyl-N-methylformamide, N-vinyl-N-ethylformamide, N-vinyl-N-propylformamide, N-vinyl-N-isopropylformamide, N-vinyl-Nn-butylformamide , N-vinyl-N-isobutylformamide, N-vinyl-Nt-butylformamide, N-vinyl-Nn-pentylformamide, N-vinyl-Nn-hexylformamide, N-vinylacetamide, N-vinyl-N-methylacetamide, N-vinyl-N ethylacetamide, N-
  • N-vinylpyrrolidone N-vinylpiperidone
  • N-vinylcaprolactam preference is given to using N-vinylpyrrolidone, while preference is given to using N-vinylformamide of the open-chain N-vinylamides.
  • Copolymers of, for example, N-vinylformamide and N-vinylpyrrolidone, which may be present in the copolymer in any desired ratio, can be used in accordance with the invention.
  • N-vinylamines in particular N-vinylamine, and N-vinylimines such as N-vinylimidazole, N-vinyl-2-methylimidazole, N-vinyl-4-methylimidazole, preferably N-vinylimidazole, as monomers for the preparation of the Use according to the invention usable copolymers.
  • Copolymers which can be used according to the invention are obtained by polymerization of monomer mixtures which as a rule contain about 0.1 to 99.9 mol%, based on the total amount of monomers used, of the at least one monomer B. These are preferably present Monomer mixtures about 50 to about 99 mol%, more preferably about 70 to about 99 mol% of the at least one monomer B.
  • the monomers B can in pure form or in the form of mixtures of two or more different of the above compounds be used.
  • the copolymers to be used according to the invention are obtained by copolymerization of at least one monomer of the formula (I) (monomer A) with at least one further monomer selected from the substance groups of the N-vinylamides or N-vinyllactams, N-vinylimines and / or N Vinyl amines (monomer B).
  • the polymerization can in principle be carried out according to all methods which appear to be suitable for a person skilled in the art. It is particularly advantageous to carry out a free radical polymerization under the conditions customary for this type of polymerization or in the presence of the reagents suitable therefor, for example free-radical initiators.
  • the copolymers have K values of at least 7, preferably from 20 to 50, particularly preferably from 25 to 45.
  • the K values are determined by H. Fikentscher, Cellulose-Chemie, Volume 13, 58 to 64 and 71 to 74 (1932) in aqueous solution at 25 ° C., at concentrations which lie between 0.1% and 5%, depending on the K value range.
  • the preparation is carried out by known methods, e.g. solution, precipitation, or reverse suspension polymerization using compounds that form radicals under the polymerization conditions.
  • the polymerization temperatures are usually in the range of 30 to 200 0 C, preferably 40 to 11 O 0 C.
  • Suitable initiators are, for example, azo and peroxy compounds, and the customary redox initiator, such as combinations of hydrogen peroxide and reducing compounds, for example Sodium sulfite, sodium bisulfite, sodium formaldehyde sulfoxilate and hydrazine.
  • the reaction medium used are all customary solvents in which the monomers are soluble.
  • alcoholic solvents such as e.g. Me ⁇ ethanol, ethanol, n-propanol or isopropanol used in pure form or in the form of their Gemi ⁇ cal.
  • the solvents mentioned can also be used in the form of mixtures with water.
  • the solids content of the resulting organic solution is usually 20 to 60 wt .-%, in particular 25 to 40 wt .-%.
  • the solvent used for the polymerization can then be removed by means of water vapor distillation and exchanged for water.
  • the solutions of the copolymers can be converted into powder form by various drying methods, such as spray drying, fluidized spray drying, drum drying or freeze drying, from which an aqueous dispersion or solution can be prepared again by redispersing in water.
  • the preparation of the copolymers which can be used according to the invention can also be carried out in the presence of suitable difunctional crosslinker components (crosslinkers) and / or in the presence of suitable regulators.
  • Suitable crosslinkers are those monomers which have a crosslinking function, for example compounds having at least two ethylenically unsaturated, non-conjugated double bonds in the molecule.
  • Examples include acrylic esters, methacrylic esters, allyl ethers or vinyl ethers of at least dihydric alcohols.
  • the OH groups of the underlying alcohols can be completely or partially etherified or esterified; however, the crosslinkers contain at least two ethylenically unsaturated groups.
  • Examples of the underlying alcohols are dihydric alcohols such as 1, 2-ethanediol, 1, 2-propanediol, 1, 3-propanediol, 1,2-butanediol, 1, 3-butanediol, 2,3-butanediol, 1, 4-butanediol , But-2-ene-1, 4-diol, 1,2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol, 1, 6-hexanediol, 1, 10-decanediol, 1, 2-dodecanediol, 1 , 12-dodecanediol, neopentyl glycol, 3-methylpentan-1, 5-diol, 2,5-dimethyl-1,3-hexanediol, 2,2,4-trimethyl-1,3-pentanediol, 1,2-cyclohexanediol,
  • ethylene oxide or propylene oxide also block copolymers au s ethylene oxide or Propyle- noxid or copolymers containing incorporated incorporated ethylene oxide and propylene oxide groups.
  • underlying alcohols having more than two OH groups are trimethylolpropane, glycerol, pentaerythritol, 1, 2,5-pentanetriol, 1, 2,6-hexanetriol, triethoxycyanuric acid, sorbitan, sugars such as sucrose, glucose, mannose.
  • the polyhydric alcohols can also be used after reaction with ethylene oxide or propylene oxide as the corresponding ethoxylates or propoxylates.
  • the polyhydric alcohols can also first be converted into the corresponding glycidyl ethers by reaction with epichlorohydrin.
  • crosslinkers are the vinyl esters or the esters of monohydric, unsaturated alcohols with ethylenically unsaturated C 3 - to C 6 -carboxylic acids, for example acrylic acid, methacrylic acid, itaconic acid, maleic acid or fumaric acid.
  • examples for such alcohols are allyl alcohol, 1-buten-3-ol, 5-hexen-1-ol, 1-octen-3-ol, 9-decene-1-ol, dicyclopentenyl alcohol, 10-undecen-1-ol, cinnamyl alcohol, citronellol , Crotyl alcohol or cis-9-octadecen-1-ol.
  • esterify the monohydric, unsaturated alcohols with polybasic carboxylic acids for example malonic acid, tartaric acid, trimellitic acid, phthalic acid, terephthalic acid, citric acid or succinic acid.
  • crosslinkers are esters of unsaturated carboxylic acids with the above-described polyhydric alcohols, for example oleic acid, crotonic acid, cinnamic acid or 10-undecenoic acid.
  • Suitable crosslinkers are also straight-chain or branched, linear or cyclic, aliphatic or aromatic hydrocarbons which have at least two double bonds which may not be conjugated to aliphatic hydrocarbons, e.g. Divinylbenzene, divinyltoluene, 1, 7-octadiene, 1, 9-decadiene, 4-vinyl-1-cyclohexene, trivinylcyclohexane or polybutadienes having molecular weights of 200 to 20,000.
  • crosslinkers are the acrylic acid amides, methacrylic acid amides and N-allylamines of at least dihydric amines.
  • amines are for example 1, 2-diaminomethane, 1, 2-diaminoethane, 1, 3-diaminopropane, 1, 4-diaminobutane, 1,6-
  • Diaminohexane, 1,12-dodecanediamine, piperazine, diethylenetriamine or isophorone diamine are also suitable.
  • amides of allylamine and unsaturated carboxylic acids such as acrylic acid, methacrylic acid, itaconic acid, maleic acid, or at leastticianwerti ⁇ conditions carboxylic acids, as described above.
  • triallylamine and triallylmonoalkylammonium salts e.g. Triallylmethylammonium chloride or methylsulfate, suitable as a crosslinker.
  • N-vinyl compounds of urea derivatives at least difunctional amides, cyanurates or urethanes, for example of urea, ethyleneurea, propyleneurea or tartaramide, e.g. N, N'-divinylethyleneurea or N, N'-divinylpropyleneurea.
  • crosslinkers are divinyldioxane, tetraallylsilane or tetravinylsilane.
  • Crosslinkers used with particular preference are, for example, methylenebisacrylamide, triallylamine and triallylalkylammonium salts, divinylimidazole, pentaerythritol triallyl ether, N, N'-divinylethyleneurea, reaction products of polyhydric alcohols with acrylic acid. or methacrylic acid, methacrylic acid esters and acrylic esters of polyalkylene oxides or polyhydric alcohols which have been reacted with ethylene oxide and / or propylene oxide and / or epichlorohydrin.
  • Very particularly preferred crosslinkers are pentaerythritol triallyl ether, methylenebisacrylamide, N, N'-divinylethyleneurea, triallylamine and triallylmonoalkylammonium salts, and acrylic esters of glycol, butanediol, trimethylolpropane or glycerol or acrylic esters of glycol, butanediol reacted with ethylene oxide and / or epichlorohydrin , Trimethylolpropane or glycerin.
  • the difunctional crosslinker component can be used in the preparation of the copolymers to be used according to the invention in amounts of from 0 up to about 5 mol%, preferably from 0 to about 3 mol%. based on the total amount of monomers used, Lucas ⁇ sets are used, either in pure form or in the form of a mixture of a plurality of crosslinkers.
  • the preparation of the copolymers which can be used according to the invention can also be carried out in the presence of suitable regulators.
  • Regulators polymerization regulators
  • Regulators are generally compounds with high transfer constants. Regulators accelerate chain transfer reactions and thus cause a reduction in the degree of polymerization of the resulting polymers without affecting the gross reaction rate.
  • regulators it is possible to distinguish between monofunctional, bifunctional or polyfunctional regulators, depending on the number of functional groups in the molecule which can lead to one or more chain transfer reactions. Suitable regulators are described, for example, in detail by K.C. Berger and G. Brandrup in J. Brandrup, E.H. Immergut, Polymer Handbook, 3rd ed., John Wiley & Sons, New York, 1989, pp. 11/81 - 11/141.
  • Suitable regulators are, for example, aldehydes, such as formaldehyde, acetaldehyde, propionic aldehyde, n-butyraldehyde, isobutyraldehyde.
  • regulators formic acid, its salts or esters, such as ammonium formate, 2,5-diphenyl-1-hexene, hydroxylammonium sulfate, and hydroxylammonium phosphate.
  • halogen compounds for.
  • alkyl halides such as tetrachloromethane, chloroform, bromotrichloromethane, bromoform, allyl bromide
  • benzyl compounds such as benzyl chloride or benzyl bromide
  • allyl compounds such as. Allyl alcohol, functionalized allyl ethers such as allyl ethoxylates, alkyl allyl ethers, or glycerol monoallyl ethers.
  • Compounds of this type are, for example, inorganic hydrogen sulfites, disulfites and dithionites or organic sulfides, disulfides, polysulfides, sulfoxides and sulfones. These include di-n-butyl sulfide, di-n-octyl sulfide, diphenyl sulfide, thiodiglycol, ethylthioethanol, diisopropyl disulfide, di-n-butyl disulfide, di-n-hexyl disulfide, diacetyl disulfide, diethanol sulfide, di-t-butyl trisulfide, dimethyl sulfoxide, dialkyl sulfide, Dialkyl disulfide and / or diaryl sulfide.
  • organic compounds containing sulfur in bonded form are particularly preferred.
  • Preferred compounds used as polymerization regulators are thiols (compounds which obtain sulfur in the form of SH groups, also referred to as mercaptans).
  • Preferred regulators are mono-, bi- and polyfunctional mercaptans, mercaptoalcohols and / or mercaptocarboxylic acids.
  • Examples of these compounds are allyl thioglycolates, ethyl thioglycolate, cysteine, 2-mercaptoethanol, 1, 3-mercaptopropanol, 3-mercaptopropane-1, 2-diol, 1, 4-mercaptobutanol, mercaptoacetic acid, 3-mercaptopropionic acid, mercaptosuccinic acid, thioglycerol, thioacetic acid , Thiourea and alkylmercaptans such as n-butylmercaptan, n-hexylmercaptan or n-dodecylmercaptan.
  • Particularly preferred thiols are cysteine, 2-mercaptoethanol, 1, 3-mercaptopropanol, 3-mercaptopropane-1, 2-diol, thioglycerol, thiourea.
  • bifunctional regulators containing two sulfur in bonded form are bifunctional thiols such as. Dimercaptopropanesulfonic acid (sodium salt), di-mercaptosuccinic acid, dimercapto-1-propanol, dimercaptoethane, dimercaptopro pan, dimercaptobutane, dimercaptopentane, dimercaptohexane, ethylene glycol bis-thioglycolates and butanediol bis-thioglycolate.
  • polyfunctional regulators are compounds containing more than two sulfur in bound form. Examples of these are trifunctional and / or tetrafunctional mercaptans.
  • Preferred trifunctional regulators are trifunctional mercaptans, such as. Trimethylolpropane tris (2-mercaptoeth- anate, trimethylolpropane tris (3-mercaptopropionate), tri- methylolpropane tris (4-mercaptobutanate), trimethylolpropane tris (5-mercaptopentanate), trimethylolpropane trisC ⁇ -mercaptohexanate), trimethylolpropane tris (2-mercaptoacetate), glyceryl thioglycolate, glyceryl thiopropionate, glyceryl thioethylate, glyceryl thiobutanate, 1, 1, 1-propanetriyl- tris (mercaptoacetate), 1,1,1-propanetriyl-tris- (mercapto-ethane), 1,1,1-propanetriyl-tris-mercaptoproprionate), 1,1,1-propanetriyl
  • trifunctional regulators are glyceryl thioglycolate, trimethylolpropane tris (2-mercaptoacetate), 2-hydroxymethyl-2-methyl-1,3-propanediol tris (mercaptoacetate).
  • Preferred tetrafunctional mercaptans are pentaerythritol tetrakis (2-mercaptoacetate), pentaerythritol tetrakis- (2-mercaptoethanoate), pentaerythritol tetrakis-mercaptopropionate), pentaerythritol tetrakis (4-mercaptobutanate), pentaerythritol tetrakis (5-mercaptopentanate), pentaerythritol tetrakis (6-mercaptohexanat).
  • polyfunctional regulators are Si compounds which are formed by reacting compounds of the formula (IIIa). Further suitable as polyfunktiona ⁇ le regulator Si compounds of the formula (NIb).
  • n is a value from 0 to 2
  • R 1 represents a C r C 6 alkyl group or phenyl group
  • R 2 denotes a C 1 -C 6 -alkyl group which denotes cyclohexyl or phenyl group
  • Z is a C 1 -C 8 alkyl group, C 2 -C 18 alkylene or is C 2 -C 18 alkynyl group, whose carbon atoms may be replaced by nonadjacent oxygen or Halo ⁇ genatome, or one of the groups
  • N C (R 3 ) 2 or - NR 3 - CR 4
  • R 3 is a C 1 -C 4 alkyl group
  • R 4 denotes a C 1 -C 18 -alkyl group.
  • controllers can be used individually or in combination with each other. In a preferred embodiment of the method, multifunctional regulators are used.
  • the regulator can be used in the preparation of the copolymers to be used according to the invention in amounts of from 0 to about 4 mol%, preferably from 0 to about 3 mol%, based on the total amount of the monomers used.
  • copolymerizable components examples include: monoethylenically unsaturated carboxylic acids having 3 to 8 carbon atoms such as acrylic acid, methacrylic acid, dimethacrylic acid, ethacrylic acid, maleic acid, citraconic acid, methylenemlonic acid, allylacetic acid, vinylacetic acid, crotonic acid, fumaric acid, mesaconic acid and itaconic acid.
  • monoethylenically unsaturated carboxylic acids having 3 to 8 carbon atoms such as acrylic acid, methacrylic acid, dimethacrylic acid, ethacrylic acid, maleic acid, citraconic acid, methylenemlonic acid, allylacetic acid, vinylacetic acid, crotonic acid, fumaric acid, mesaconic acid and itaconic acid.
  • Acrylic acid, methacrylic acid, maleic acid or mixtures of said carboxylic acids are preferably used from this group of monomers.
  • the monoethylenically unsaturated carboxylic acids may be in the form of the free acid and, if present, the anhydrides or in partially or completely neutralized form be used in the copolymerization.
  • Suitable monomers C are, for example, the C 1 -C 30 -alkyl esters, amides and nitriles of the abovementioned carboxylic acids, for example methyl acrylate, ethyl acrylate, methyl methacrylate, ethyl methacrylate, hydroxyethyl acrylate, hydroxypropyl acrylate, hydroxybutyl acrylate, hydroxyethyl methacrylate, hydroxypropyl methacrylate, hydroxyisobutyl acrylate, Hydroxyisobutyl methacrylate, octyl acrylate, 2-ethylhexyl acrylate, 2-ethylhexyl methacrylate, nonyl acrylate, decyl acrylate, lauryl acrylate, myristyl acrylate, cetyl acrylate, stearyl acrylate, oleyl acrylate, behenyl acrylate, hex
  • suitable monomers C are monomethyl maleate, dimethyl maleate, monoethyl maleate, diethyl maleate, acrylamide, methacrylamide, N, N-dimethylacrylamide, N-tert-butylacrylamide, acrylonitrile, methacrylonitrile, dimethylaminoethyl acrylate, diethylaminoethyl acrylate, diethylaminoethyl methacrylate and the salts of last-mentioned monomers with carboxylic acids or mineral acids and the quaternized products.
  • C suitable monomers are N-alkyl- or N, N-dialkyl-substituted carboxamides of acrylic acid or methacrylic acid, wherein the alkyl radicals are C, -.
  • C 18 alkyl or cycloalkyl is, for example, N-diethylacrylamide, N-isopropylacrylamide, dimethylaminopropylmethacrylamide, N-tert-octylacrylamide, N-stearylacrylamide, N-stearylmethacrylamide, N-octylacrylamide, N, N-dioctylacrylamide, N, N-dioctylmethacrylamide, N-cetylacrylamide, N-cetylmethacrylamide, N-dodecylacrylamide, N-dodecylmethacrylamide, N-myristylacrylamide or 2-ethylhexylacrylamide.
  • vinyl esters of aliphatic carboxylic acids C 1 - to C 30 -carboxylic acids
  • Suitable monomers C are furthermore the vinyl ethers, for example octadecyl vinyl ether.
  • copolymerizable monomers C acrylamidoglycolic acid, vinylsulfonic acid, allylsulfonic acid, methallylsulfonic acid, styrenesulfonic acid, 3-sulfopropyl acrylate, 3-sulfopropyl methacrylate and acrylamidomethylpropanesulfonic acid and phosphonic acid containing monomers such as vinylphosphonic acid, allylphosphonic and acrylamidomethanepropanephosphonic acid.
  • Another copolymerizable monomer C is called diallyl ammonium chloride.
  • the monomers C mentioned can be used both individually and in the form of mixtures of several of the compounds mentioned according to the invention.
  • the one or more further monomers C can be used in the preparation of the copolymers to be used according to the invention in amounts of 0 to about 49 mol%, based on the total amount of the monomers used.
  • the invention relates to the use of copolymers as solubilizers, which are obtainable by polymerization of:
  • R 1 , R 2 each independently of one another are H or CH 3 , R 3 is phenyl and n is an integer from 1 to 10,
  • the invention relates to copolymers obtainable by polymerization of
  • R1 and R2 are each independently H or CH 3,
  • R 3 is C 6 -C 10 -aryl or C 7 -C 12 -aralkyl which may carry one or more preferably 1 to 3 identical or different C 1 -C 9 -alkyl and / or C 1 -C 5 -alkoxy substituents, and
  • n 1 or 2
  • the present invention provides amphiphilic compounds for use as solubilizers for pharmaceutical and cosmetic preparations as well as food preparations. They have the property of solubilizing sparingly soluble active ingredients in the field of pharmacy and cosmetics, sparingly soluble dietary supplements, for example vitamins and carotenoids, but also sparingly soluble active substances for use in crop protection agents and veterinary active agents.
  • copolymers to be used according to the invention are particularly suitable for use as solubilizers in solid solutions.
  • the copolymer copolymers to be used according to the invention can be used as solubilizers in cosmetic formulations.
  • they are suitable as solubilizers for cosmetic oils. They have a good solubilizing ability for fats and oils, such as peanut oil, jojoba oil, coconut oil, almond oil, olive oil, palm oil, castor oil, soybean oil or wheat germ oil or for essential oils such as mountain pine oil, lavender oil, rosemary oil, pine needle oil, pine needle oil, eucalyptus oil, peppermint oil , Sage oil, bergamot oil, turpentine oil, lemon balm oil, sage oil, juniper oil, lemon oil, aniseed oil, cardamom oil; Peppermint oil, camphor oil etc. or for mixtures of these oils.
  • the copolymers to be used according to the invention can be used as solubilizers for UV absorbers which are sparingly soluble or insoluble in water as mentioned below.
  • UV absorber is to be understood in the context of the present invention broadly and includes UV-A, UV-B and / or broadband filters.
  • UV-A or UV-B filter substances are, for example, representatives of the following classes of compounds:
  • R 7 , R 8 and R 9 are independently selected from the group of ver ⁇ branched and unbranched alkyl groups having 1 to 10 carbon atoms or represent a single hydrogen atom.
  • R 7 , R 8 and R 9 are independently selected from the group of ver ⁇ branched and unbranched alkyl groups having 1 to 10 carbon atoms or represent a single hydrogen atom.
  • Especially preferred are 2,4-bis - ⁇ [4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl ⁇ -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: Aniso Tria - zin), which is available under the trade name Tinosorb ® S from CIBA-Chemikalien GmbH.
  • UV filter substances which are the structural motif
  • R 13 is a branched or unbranched C 1 -C 12 -alkyl radical, a C 5 -C 12 -cycloalkyl radical, optionally substituted by one or more C 1 -C 4 -alkyl groups,
  • R 14 is a branched or unbranched C 1 -C 8 -alkyl radical, a C 5 -C 12 -cycloalkyl radical, optionally substituted by one or more C 1 -C 4 -alkyl groups, or a hydrogen atom, an alkali metal atom, an ammonium group or a group the formula
  • A is a branched or unbranched C 1 -C 18 -alkyl radical, a
  • R 16 represents a hydrogen atom or a methyl group
  • n a number from 1 to 10
  • R 15 is a branched or unbranched C- ⁇ -C 18 alkyl, a
  • C 5 -C 12 -cycloalkyl radical optionally substituted with one or more C 1 -C 4 -alkyl groups, when X represents the NH-group, and a branched or unbranched C r C 18 -alkyl radical, a C 5 -Ci 2 Cycloalkyl group optionally substituted with one or more C 1 -C 4 alkyl groups, or a hydrogen atom, an alkali metal atom, an ammonium group or a group of the formula
  • 5 C is a branched or unbranched CrC ⁇ alkyl, C 12 cycloalkyl or aryl radical, optionally substituted with ei ⁇ ner or more C r C 4 alkyl groups,
  • R represents a hydrogen atom or a methyl group
  • n a number from 1 to 10
  • UV filter substance in the context of the present invention is also an asymmetrically substituted s-triazine, its chemical structure by the formula
  • Dioctylbutylamidotriazon (INCI: Diethylhexylbutamidotriazone) and under the trade name UVASORB ® HEB available from Sigma 3V.
  • a symmetrically substituted s-triazine which comprises 4,4 ', 4 "- (1,3,5-triazine-2,4,6-triyltriimino) -trisbenzoic acid tris (2-ethylhexyl ester), synonym: 2,4,6-tris [anilino- (p-carbo-2'-ethyl-1 '- hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone) , which is marketed by BASF Aktienge ⁇ society under the trade name Uvinul ® T 150th
  • European published patent application 775,698 also describes preferably bis-resorcinyl triazine derivatives to be solubilized in the manner according to the invention, the chemical structure of which is given by the generic formula
  • R 17 and R 18 are, inter alia, C 3 -C 18 -alkyl or C 2 -C 18 -alkenyl and A 1 is an aromatic radical.
  • 2,4-bis - ⁇ [4- (3-sulfonato) -2-hydroxy-propyloxy) -2-hydroxy] -phenyl ⁇ -6- (4-methoxyphenyl) are also to be advantageously solubilized ) -1, 3,5-triazine sodium salt containing 2,4-bis - ⁇ [4- (3- (2-propyloxy) -2-hydroxy-propyloxy) -2-hydroxy] -phenyl ⁇ -6- (4 -methoxyphenyl) -1,3,5-triazine which is 2,4-bis - ⁇ [4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl ⁇ -6- [4- (2-methoxyethylcarboxyl ) - phenylamino] -1, 3,5-triazine, the 2,4-bis - ⁇ [4- (3- (2-propyloxy) -2-hydroxy-propy
  • Advantageous oil-soluble UV-B and / or broadband filter substances to be solubilized by the use according to the invention are, for example:
  • 3-benzylidene camphor derivatives preferably 3- (4-methylbenzylidene) camphor, 3-benzylidene camphor;
  • 4-aminobenzoic acid derivatives preferably 2-ethylhexyl 4- (dimethylamino) benzoate, 4- (dimethylamino) benzoic acid amyl ester,
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone (under the trade name Uvinul ® M40 from the Fa. BASF available) 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4 ⁇ methoxybenzophenone, 2,2 ', 4,4'-tetrahydroxybenzophenone (available under the trade name Uvinul ® D 50 from the Fa. BASF).
  • liquid at room temperature UV filter substances in the context of the present invention are Homomenthylsali- cylate, 2-ethylhexyl-2-cyano-3,3-diphenyl, 2-ethylhexyl-2-hydroxybenzoate and esters of cinnamic acid, preferably 4-methoxycinnamic acid (2-ethylhexyl) ester and 4-methoxycinnamic acid isopentyl ester.
  • Homomenthyl salicylate (INCI: Homosalate) is characterized by the following structure:
  • 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (INCI: Octocrylene) is available from BASF under the name Uvinul ® N 539T and is characterized by the following structure:
  • 2-ethylhexyl-2-hydroxybenzoate (2-ethylhexyl salicylate, octyl salicylate, INCI: Ethylhexyl Salicylate) is available, for example, from Haarmann & Reimer under the trade name Neo Heliopan OS ® and is characterized by the following structure:
  • 4-methoxycinnamate (2-ethylhexyl) ester (2-ethylhexyl 4-methoxycinnamate, INCI: Ethylhexyl Methoxycinnamate) is, for example, from BASF under the Uvinul glassesbezeich ⁇ voltage ® MC 80 and is characterized by the following structure.:
  • 4-methoxycinnamate isopentyl 4-methoxycinnamate, INCI: Isoamyl p-Methoxycinnamate
  • Advantageous dibenzoylmethane derivatives according to the present invention are, more particularly, 4- (tert-butyl) -4'-methoxydibenzoylmethane sondere (CAS no. 70356-09-1), soft by BASF under the trademark Uvinul ® from Merck and BMBM planning under the glassesbezeich ⁇ Eusolex ® sold 9020 is characterized by the following structure:
  • Another advantageous dibenzoylmethane derivative is 4-isopropyl-dibenzoylmethane (CAS no. 63250-25-9), which is sold by Merck under the name Eusolex ® 8020th
  • the Eusolex 8020 is characterized by the following structure:
  • R 19 and R 20 independently of one another are linear or branched, saturated or unsaturated, substituted (for example substituted by a phenyl radical) or unsubstituted alkyl radicals having 1 to 18 carbon atoms.
  • a benzotriazole to be advantageously solubilized in the context of the present invention is also the 2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy] disi oxanyl] propyl] phenol (CAS No .: 155633-54-8) with the INCI name Drometrizole trisiloxane, which sold by Chimex under the trademark metal xoryl XL ®!. is and by the following chemical structural formula
  • benzotriazoles to be solubilized in the context of the present invention are [2,4'-dihydroxy-3- (2H-benzotriazol-2-yl) -5- (1,1,3,3-tetramethylbutyl) -2'- n -octoxy-5'-benzoyl] diphenylmethane, 2,2'-methylenebis [6- (2H-benzotriazol-2-yl) -4- (methyl) phenol], 2,2'-methylene-bis- [ 6- (2H-Benzotriazol-2-yl) -4- (1,1,3,3-tetramethyl-butyl) -phenol], 2- (2'-hydroxy-5'-octyl-phenyl) -benzotriazole, 2- (2 '-Hydroxy-3', 5'-di-t-amylphenyl) benzotriazole and 2- (2'-hydroxy-5'-methylphenyl) benzotriazole.
  • Another UV filter to be advantageously solubilized in the context of the present invention is the diphenylbutadiene compound described in EP-A-0 916 335 of the following formula:
  • UV-A filter to be advantageously solubilized for the purposes of the present invention is the 2- (4-ethoxy-anilinomethylene) -propanedicarboxylic acid diethyl ester of the following formula described in EP-A-0 895 776.
  • the present invention therefore also relates to cosmetic preparations which comprise at least one of the copolymers of the abovementioned composition to be used according to the invention as solubilizers.
  • cosmetic preparations which comprise at least one of the copolymers of the abovementioned composition to be used according to the invention as solubilizers.
  • Preference is given to those preparations which, in addition to the solubilizer, contain one or more sparingly soluble cosmetic active ingredients, for example the abovementioned oils or UV absorbers or else dyes.
  • solubilizates based on water or water / alcohol.
  • the solubilizers to be used according to the invention are used in a ratio of 0.2: 1 to 20: 1, preferably 1: 1 to 15: 1, more preferably 2: 1 to 12: 1 to the sparingly soluble cosmetic active ingredient.
  • solubilizer to be used according to the invention in the cosmetic preparation is, depending on the active ingredient, in the range from 1 to 50% by weight, preferably 3 to 40% by weight, particularly preferably 5 to 30% by weight.
  • auxiliaries may be added to this formulation, for example nonionic, cationic or anionic surfactants such as alkylpolyglycosides, fatty alcohol sulfates, fatty alcohol ether sulfates, alkanesulfonates, fatty alcohol ethoxylates, fatty alcohols.
  • nonionic, cationic or anionic surfactants such as alkylpolyglycosides, fatty alcohol sulfates, fatty alcohol ether sulfates, alkanesulfonates, fatty alcohol ethoxylates, fatty alcohols.
  • alcohol phosphates alkyl betaines, sorbitan esters, POE sorbitan esters, sugar fatty acid esters, fatty acid polyglycerol esters, fatty acid partial glycerides, fatty acid carboxylates, fatty alcohol sulfosuccinates, fatty acid sarcosinates, fatty acid isethionates, fatty acid taurinates, citric acid esters, silicone copolymers, fatty acid polyglycol esters, fatty acid amides, fatty acid alkanolamides, quaternary ammonium compounds, alkylphenol oxethylates, fatty amine oxethylates , Cosolvents such as ethylene glycol, propylene glycol, glycerin and others.
  • natural or synthetic compounds e.g. Lanolin derivatives, cholesterol derivatives, isopropyl myristate, isopropyl palmitate, electrolytes, dyes, preservatives, acids (for example lactic acid, citric acid) are added.
  • compositions are used, for example, in bath-supplement preparations such as bath oils, shaving waters, face lotions, mouthwashes, hair lotions, colognes, toilet water and in sunscreens.
  • the copolymers to be used according to the invention can be used as 100% substance or preferably as aqueous solution.
  • the solubilizer is usually dissolved in water and intensively mixed with the sparingly soluble cosmetic active ingredient to be used in each case.
  • solubilizer it is also possible for the solubilizer to be intensively mixed with the sparingly soluble cosmetic active ingredient to be used in each case and then mixed with demineralized water with constant stirring.
  • copolymers to be used according to the invention are also suitable for use as solubilizers in pharmaceutical preparations of any kind, which are characterized in that they contain one or more sparingly soluble or water-insoluble active ingredients or drugs as well as vitamins and / or carotenoids can.
  • these are aqueous solutions or solubilisates for oral or parenteral administration.
  • copolymers to be used according to the invention are suitable for their properties.
  • emulsions for example fat emulsions
  • the copolymers of the invention are to process a sparingly soluble drug.
  • Pharmaceutical formulations of the abovementioned type can be obtained by processing the copolymers to be used according to the invention with pharmaceutical active substances by conventional methods and using known and new active compounds.
  • the application according to the invention may additionally contain pharmaceutical excipients and / or diluents.
  • Cosolvents, stabilizers, preservatives are especially listed as auxiliaries.
  • the pharmaceutical active ingredients used are water-insoluble or sparingly soluble substances. According to DAB 9 (German Pharmacopoeia), the solubility of active pharmaceutical ingredients is adjusted as follows: sparingly soluble (soluble in 30 to 100 parts of solvent); poorly soluble (soluble in 100 to 1000 parts of solvent); practically insoluble (soluble in more than 10,000 parts solvent).
  • the active substances can come from any indication range.
  • Examples of drug classes or active substances that can be brought into solution by the copolymers to be used according to the invention include: benzodiazepines, antihypertensives, vitamins, cytostatics - in particular taxol, anesthetics, neuroleptics, antidepressants, antibiotics, antimycotics, fungicides, Chemotherapeutic agents, urologics, platelet aggregation inhibitors, sulfonamides, spasmolytics, hormones, immunoglobulins, serums, thyroid therapeutics, psychotropic drugs, Parkinson and other antihyperkinetics, ophthalmics, neuropathy preparations, calcium metabolism regulators, muscle relaxants, narcosis middle I, lipid-lowering, hepatic, coronary , Cardiaka, immunotherapeutics, regulatory peptides and their inhibitors, hypnotics, sedatives, gynecologics, gout, fibrinolytics, enzyme preparations and transport proteins, enzyme inhibitors,
  • Atherosclerosis agents antiphlogistics, anticoagulants, antihypotonics, antihypoglycemics, antihypertensives, antifibrinolytics, antiepileptics, antiemetics, antidotes, antidiabetics, antiarrhythmics, antianemics, antiallergics, anthelmintics, analgesics, analeptics, aldosterone antagonists, weight loss agents.
  • a possible preparation variant is the dissolution of the solubilizer in the aqueous phase, optionally with gentle heating, and the subsequent dissolution of the active ingredient in the aqueous solubilizer solution.
  • the simultaneous dissolution of solubilizer and active ingredient in the aqueous phase is also possible.
  • copolymers as solubilizers can, for example, also be carried out in such a way that the active ingredient in the solubilizer, if necessary with heating, dispersed and mixed with stirring with water.
  • the invention therefore also relates to pharmaceutical preparations which contain at least one of the copolymers to be used according to the invention as solubilizer. Preference is given to those preparations which, in addition to the solubilizer, contain a pharmaceutically active substance which is sparingly soluble in water or insoluble in water, for example from the abovementioned indication areas.
  • Particularly preferred of the abovementioned pharmaceutical preparations are those which are parenterally administrable formulations.
  • the content of solubilizer according to the invention in the pharmaceutical preparation is, depending on the active ingredient, in the range from 1 to 50 wt .-%, preferably 3 to 40 wt .-%, particularly preferably 5 to 30 wt .-%.
  • Another aspect of the present invention relates to the use of said copolymers as solubilizers in molecularly dispersed systems.
  • Solid dispersions ie homogeneous very finely divided phases of two or more solids and their special case of so-called “solid solutions” (molecular disperse systems), and their use in pharmaceutical technology are generally known (see Chiou and Riegelmann, J. Pharm. Sci., 1971, 60, 1281-1300.
  • the present invention also relates to solid solutions containing at least one copolymer to be used according to the invention.
  • the preparation of solid solutions can be carried out by means of melt processes or by the solution process.
  • Solubilizers for the preparation of such solid dispersions or solid solutions are the copolymers of the invention.
  • a copolymer for the preparation of a solid solution and the subsequent formulation of a solid dosage form containing 200 mg of an active substance e.g. Carbamazepine contains described.
  • the copolymer selected by way of example consists of 98 mol% of N-vinylpyrrolidone and 2 mol% of phenoxyacrylate.
  • carbamazepine and the selected copolymer can be weighed and mixed in the desired ratio, for example in equal parts.
  • a free-fall mixer is suitable for mixing.
  • the mixture can then be extruded, for example in a twin-screw extruder.
  • the diameter of the thus obtained, cooled product strand, consisting of a solid solution of the chosen active ingredient in the selected copolymer to be used according to the invention is dependent on the diameter of the perforation of the perforated disks of the extruder.
  • cylindrical particles can be obtained whose height depends on the distance between the perforated disk and the knife.
  • the average diameter of the cylindrical particles is usually about 1000 to about 3000 microns, the height usually about 2000 to about 5000 microns. Larger extrudates can be crushed in a subsequent step.
  • the solution is usually poured into a suitable mold, and the solvent, for example by drying, removed.
  • the drying conditions are advantageously chosen according to the properties of active ingredient (e.g., thermolability) and solvent (e.g., boiling point).
  • the resulting molding or extrudate can be comminuted, for example, with a suitable mill (for example, pin mill).
  • the solid solution is advantageously comminuted to a mean General ⁇ chen standing of less than about 2000 microns, preferably less than about 1000 microns and more preferably less than about 500 microns.
  • the resulting bulk material can now be processed into a tableting mixture or to a capsule filling material.
  • the tableting is advantageously carried out by obtaining tablets having a hardness of greater than about 35 N, preferably greater than about 60 N, particularly preferably from about 80 to about 100 N.
  • formulations thus obtainable may, as in the case of conventional formulations, if necessary be coated with suitable coating materials for the purpose of obtaining gastric juice resistance, retarding, taste masking, etc.
  • the copolymers to be used according to the invention are also suitable as solubilizers in the food sector for nutrients, auxiliaries or additives which are sparingly soluble in water or insoluble in water, for example fat-soluble vitamins or carotenoids. Examples include clear, colored with carotenoids drinks.
  • the invention therefore also relates to food-grade technical preparations which contain at least one of the copolymers to be used according to the invention as a solubilizer.
  • food supplements also include food supplements, such as preparations containing food coloring matter and dietetic foods. stand.
  • the said copolymers are also suitable as solubilizers for feed additives for animal nutrition.
  • compositions include pesticides, herbicides, fungicides or insecticides, especially those preparations of Pflan ⁇ zenstoffschn that are used as spray or pouring broths.
  • Example 3 Preparation of the copolymer 3
  • a solution consisting of 5 g of vinylpyrrolidone and 100 g of isopropanol was heated to 8O 0 C under a nitrogen atmosphere.
  • a second solution consisting of 10 g of 2- phenoxyethyl acrylate (Laromer ® POEA, BASF Aktiengesellschaft) and 200 g isopropanol precipitation was added over 5 h nol.
  • a third solution consisting of 85.0 g of vinylpyrrolidone and 200 g of isopropanol was added over a period of 5.5 hours and a fourth solution consisting of 4.0 g of tert-butyl perpivalate (75% strength) and 50 g of isopropanol added within 6.0 h. After a further hour, the product was dried under vacuum at 75 0 C.
  • a solution consisting of 5 g of vinylpyrrolidone and 100 g of isopropanol was heated to 80 ° C. under a nitrogen atmosphere.
  • a second solution consisting of 10 g of polyethylene glycol phenyl ether acrylate (M n 280 D, Aldrich) and 200 g of isopropanol was added within 5 h.
  • a third solution consisting of 85.0 g of vinylpyrrolidone and 200 g of isopropanol was added within 5.5 h and a fourth solution consisting of 4 g of tert-butyl perpivalate (75%) and 50 g of isopropanol was added within 6 h.
  • the product was dried under vacuum at 75 ° C.
  • the polymer thus obtained had a K value of 13.7 (1% in water).
  • a solution consisting of 5 g of vinylpyrrolidone and 100 g of isopropanol was heated to 80 ° C. under a nitrogen atmosphere.
  • a second solution consisting of 10 g of polyethylene glycol-phenyl ether acrylate (1 ⁇ 324 D, Aldrich) and 200 g of isopropanol was added over 5 h.
  • a third solution consisting of 85.0 g of vinylpyrrolidone and 200 g of isopropanol was added over 5.5 h and a fourth solution consisting of 4.0 g of tert-butyl perpivalate (75%) and 50 g of isopropanol within 6, 0 h added.
  • the product was dried under vacuum at 75 ° C.
  • the resulting polymer had a K value of 14.8 (1% in water).
  • a third solution consisting of 17.7 g of ethanol, 17.7 g of water and 0.8 g of 2,2'-azobis (2-amidinopropane) dihydrochloride (Wako V50, Wako) was added within 5 h. After a further 2 hours, the product was subjected to steam distillation and dried at 7O 0 C under vacuum.
  • 2-phenoxyethyl acrylate Laromer® POEA, BASF Aktiengesellschaft
  • a solid solution prepared as in Example 17 consisting of 50% by weight of one of the active ingredients carbamazepine, clotrimazole, piroxicam or estradiol and 50% by weight of a copolymer of 98 mole% N-vinylpyrrolidone and 2 mole% phenoxyacrylate, the disintegrant , the binder and flow control agent were weighed and mixed in a tumbler mixer for 10 minutes. The lubricant was then added and mixed again for 5 minutes. The bulk material was pressed on a rotary press at a pressing pressure of 20 kN (punch: oblong, with breaking notch). Friability, disintegration and drug release are in accordance with the specifications of the pharmacopoeia.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne l'utilisation de copolymères comme agents de solubilisation, lesquels copolymères sont obtenus par polymérisation a) d'au moins un composé de formule (I) (monomère A), dans laquelle R1 et R2 désignent indépendamment l'un de l'autre H ou CH<SUB>3</SUB> ; R3 = aryle en C<SUB>6</SUB>-C<SUB>10</SUB> ou aralkyle en C<SUB>7</SUB>-C<SUB>12</SUB>, pouvant présenter un ou plusieurs substituants alkyle en C<SUB>1</SUB>-C<SUB>9</SUB> et/ou alcoxy en C<SUB>1</SUB>-C<SUB>5</SUB> identiques ou différents, et n désigne un nombre entier de 0 à 100, b) d'au moins un composé sélectionné dans le groupe constitué par les N-vinylamides, les N-vinyllactames, les N-vinylimines et les N-vinylamines présentant 2 à 15 atomes de carbone (monomère B), c) éventuellement d'un ou de plusieurs constituants de réticulation difonctionnels différents, d) éventuellement d'un ou de plusieurs régulateurs différents et e) éventuellement d'un ou de plusieurs autres constituants copolymérisables (monomère C).
EP05783769A 2004-08-18 2005-08-03 Utilisation de copolymeres amphiphiles comme agents de solubilisation Withdrawn EP1781719A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004040104A DE102004040104A1 (de) 2004-08-18 2004-08-18 Verwendung von amphiphilen Copolymerisaten als Solubilisatoren
PCT/EP2005/008408 WO2006018135A1 (fr) 2004-08-18 2005-08-03 Utilisation de copolymeres amphiphiles comme agents de solubilisation

Publications (1)

Publication Number Publication Date
EP1781719A1 true EP1781719A1 (fr) 2007-05-09

Family

ID=35511147

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05783769A Withdrawn EP1781719A1 (fr) 2004-08-18 2005-08-03 Utilisation de copolymeres amphiphiles comme agents de solubilisation

Country Status (7)

Country Link
US (1) US20080153925A1 (fr)
EP (1) EP1781719A1 (fr)
JP (1) JP2008510043A (fr)
CN (1) CN101080426A (fr)
CA (1) CA2577431A1 (fr)
DE (1) DE102004040104A1 (fr)
WO (1) WO2006018135A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11453050B2 (en) 2018-04-27 2022-09-27 Wirtz Manufacturing Company, Inc. Battery machine tool system and method

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
CN101873801B (zh) * 2007-09-27 2014-12-10 巴斯夫欧洲公司 内吸提高剂
AU2008334580A1 (en) * 2007-12-12 2009-06-18 Basf Se Salts of active ingredients with polymeric counter-ions
WO2009103760A2 (fr) * 2008-02-21 2009-08-27 Basf Se Granules inertes enrobés
US9801372B2 (en) 2009-05-11 2017-10-31 Basf Se Polymers for increasing the soil mobility of low-solubility insecticides
EP2611847B1 (fr) * 2010-09-01 2018-11-07 Basf Se Amphiphile servant à solubiliser des substances actives difficilement solubles
JP7195771B2 (ja) * 2018-06-11 2022-12-26 株式会社日本触媒 ポリビニルピロリドン重合体の製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207867A1 (es) * 1974-07-04 1976-11-08 Smith & Nephew Res Un copolimero hidrogel ligeramente entrelazado
US4071508A (en) * 1975-02-11 1978-01-31 Plastomedical Sciences, Inc. Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates
GB1514810A (en) * 1976-08-19 1978-06-21 Patel S Crosslinked polymers
US4946967A (en) * 1988-11-03 1990-08-07 Gaf Chemicals Corporation Polymerizable derivatives of 5-oxo-pyrrolidinecarboxylic acid
JPH09241335A (ja) * 1996-03-08 1997-09-16 Nippon Shokubai Co Ltd 難燃材
DE19719187A1 (de) * 1997-05-07 1998-11-12 Basf Ag Verwendung von Copolymerisaten des N-Vinyl-pyrrolidons in Zubereitungen wasserunlöslicher Stoffe
US5942120A (en) * 1997-12-04 1999-08-24 Wilkinson; Kenneth Composite microporous ultrafiltration membrane, method of making thereof, and separation methods
DE19811919A1 (de) * 1998-03-18 1999-09-23 Basf Ag Verwendung von Copolymerisaten monoethylenisch ungesättigter Carbonsäuren als Solubilisatoren
DE19814739A1 (de) * 1998-04-02 1999-10-07 Basf Ag Verwendung von Polyalkylenoxid-haltigen Pfropfpolymerisaten als Solubilisatoren
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2006018135A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11453050B2 (en) 2018-04-27 2022-09-27 Wirtz Manufacturing Company, Inc. Battery machine tool system and method

Also Published As

Publication number Publication date
WO2006018135A1 (fr) 2006-02-23
DE102004040104A1 (de) 2006-02-23
JP2008510043A (ja) 2008-04-03
CN101080426A (zh) 2007-11-28
US20080153925A1 (en) 2008-06-26
CA2577431A1 (fr) 2006-02-23

Similar Documents

Publication Publication Date Title
EP1781719A1 (fr) Utilisation de copolymeres amphiphiles comme agents de solubilisation
EP1945183B1 (fr) Utilisation de copolymeres en tant que solubilisants de composes peu solubles dans l&#39;eau
EP1913039B1 (fr) Copolymere contenant des groupes de silicone, sa production et son utilisation
EP1805236B1 (fr) Copolymeres amphoteres de methacrylate d&#39;ethyle et leur utilisation
EP1913038B1 (fr) Copolymere ampholyte, sa production et son utilisation
EP2173781A1 (fr) Procédé de fabrication de copolymères à base de polyéthers sous forme solide pouvant être obtenus par polymérisation-greffage en solution
EP0953347A2 (fr) Utilisation de polymères greffés d&#39;oxyde de polyalkylène en tant qu&#39;agents solubilisants
EP1863858A1 (fr) Polymeres cationiques utilises comme epaississants de compositions aqueuses et alcooliques
EP2066705A1 (fr) Polymères cationiques servant d&#39;épaississants pour des compositions aqueuses et alcooliques
EP2029107A2 (fr) Utilisation de copolymères acétate de vinyle-sulfonate comme solubilisant pour des composés difficilement solubles dans l&#39;eau
EP2324068A2 (fr) Polymérisation par précipitation en présence de monostéarate de glycérine
EP0948957B1 (fr) Usage de copolymères d&#39;acides carboxyliques insaturés monoéthyléniquement comme solubilisants
EP1915407A2 (fr) Copolymeres a base de n-vinylcaprolactame et leur utilisation comme solubilisants
WO2007020203A1 (fr) Copolymeres anioniques, ampholytiques destines a des compositions faiblement volatiles
DE102004051648A1 (de) Anionische Ethylmethacrylat-Copolymere und deren Verwendung
EP1913041A1 (fr) Copolymeres a base de n-vinylpyrrolidone et d&#39;acides carboxyliques aliphatiques ramifies, et leur utilisation en tant que solubilisateurs
DE10259815A1 (de) Polymere enthaltend Pyrrolidon-4-carbonsäuregruppen und deren Verwendung
DE102009054532A1 (de) Verfahren zur Herstellung von Partikeln umfassend wasserlösliche Polymere
DE102005003010A1 (de) Copolymere für kosmetische Mittel, hergestellt in Gegenwart polyfunktioneller Regler
DE10219889A1 (de) Kosmetisches Mittel enthaltend wenigstens ein wasserlösliches Copolymer mit (Meth)acrylsäureamideinheiten
DE10350359A1 (de) Kosmetisches Mittel enthaltend ein Copolymer mit (Meth)acrylsäureamideinheiten und einen Ester der p-Aminobenzoesäure
DE102005013037A1 (de) Vinylimidazol-Polymerisate als Verdicker für wässrige Zusammensetzungen
DE10243573A1 (de) Kosmetisches Mittel enthaltend wenigstens ein wasserlösliches Copolymer mit (Meth)acrylsäureamideinheiten

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070319

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BASF SE

17Q First examination report despatched

Effective date: 20120608

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121219